Journal profile · PHARMACOLOGY & PHARMACY
International Journal of Pharmacy Practice
ISSN 0961-7671 · eISSN 2042-7174 · Oxford University Press
International Journal of Pharmacy Practice: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.9 (journal website); hybrid open access; APC about USD 3,070; median 204 days to acceptance (110 articles, last 24 months); 247 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
International Journal of Pharmacy Practice is published by Oxford University Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical Practices and Patient Outcomes, Medication Adherence and Compliance and Antibiotic Use and Resistance, together about 47.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The International Journal of Pharmacy Practice (IJPP) is a Medline-indexed, peer-reviewed, international journal publishing innovative research at the intersection of pharmacy, medicines, and healthcare. It is a great source for creating evidence-based policy and informing practice for all healthcare professionals and policymakers. IJPP is a multidisciplinary journal reflecting the increasingly collaborative approach in the delivery of healthcare. Topics include (but are not limited to): Safe and effective medicine use: e.g., medication adherence; polypharmacy; deprescribing; pharmacoepidemiology; pharmacovigilance, drug safety; antimicrobial stewardship; advanced therapy medicinal products (ATMPs). Health promotion and public health: e.g., cardiovascular disease, mental health; smoking cessation, healthy eating and exercise; reproductive/sexual health and HIV; substance use; vaccination; pharmacy disaster planning. Education: e.g., pharmacy education, training, and workforce development; health education relevant to medicines. Emerging areas: e.g., stratified medicine and pharmacogenomics; digital health and big data; skill mix and service redesign; new technologies; telepharmacy, and automation. Clinical management of long-term illnesses including behavioural approaches: e.g. asthma, cancer, cardiovascular disease, diabetes, mental health and age-related conditions. Methodological articles developing new approaches or drawing on other disciplines e.g., anthropology, health economics, psychology, sociology, statistics. Methods include both evaluative and exploratory work including: structured reviews of the literature such as systematic or scoping reviews; randomised controlled trials, controlled trials, before and after studies, observational studies; intervention development including feasibility studies; epidemiological approaches, surveys, case studies, simulated client studies; interviews and focus groups.
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Christine BondPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 7, Australia 6, South Africa 3, Canada 2, United States 1 (22 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmaceutical Practices and Patient OutcomesMedicine33%
- Medication Adherence and ComplianceMedicine8.4%
- Antibiotic Use and ResistanceImmunology and Microbiology5.9%
- Innovations in Medical EducationMedicine5%
- Pharmaceutical studies and practicesMedicine4.9%
- Patient Safety and Medication ErrorsHealth Professions4.3%
- Nursing Roles and PracticesHealth Professions3.3%
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCAB AbstractsCINAHLPublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 2.9Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.3Publisher website ·
- CiteScore 2026-06
- 2.9LetPub ·
- CiteScore (publisher) 2025
- 2.9Publisher website ·
- SJR 2026-06
- 0.52LetPub ·
- SNIP 2026-06
- 0.77LetPub ·
- h-index
- 58OpenAlex ·
- i10-index
- 890OpenAlex ·
- 2-year mean citedness
- 0.8OpenAlex ·
- Self-citation rate
- 12%LetPub ·
- Share of gold OA articles
- 45.02%LetPub ·
Volume
- Articles per year
- 149LetPub ·
- Downloads per year (publisher) 2025
- 254,557Publisher website ·
Articles by year OpenAlex count · 3,591 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 215 | 89 | 30 |
| 2025 | 247 | 150 | 181 |
| 2024 | 241 | 165 | 351 |
| 2023 | 219 | 203 | 721 |
| 2022 | 233 | 173 | 723 |
| 2021 | 153 | 94 | 812 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
204 daysMedian, submission to acceptance · P25–P75 148 days – 286 days
- Acceptance to online
- median 27 days (68 articles)
- Submission to online
- median 233 days
- Sample
- 110 articles with submission and acceptance dates (309 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision 2025
- 44 daysPublisher website ·
- Submission to final decision 2025
- 91 daysPublisher website ·
- Acceptance to publication
- 42.5 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | GBP 2,328 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open access options
IJPP offers authors the option of publishing under a standard licence or an open access licence. There is no charge to publish under a standard licence. If publishing open access, authors will need to pay an open access charge. Details of the open access licences and open access charges. Oxford University Press (OUP) has a growing number of Read and Publish agreements with institutions and consort…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- ISSN
- 0961-7671
- Electronic ISSN
- 2042-7174
- Latest issue on the website
- Volume 34, Issue 4 (August 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about International Journal of Pharmacy Practice
What CAS zone is International Journal of Pharmacy Practice in?
In the 2025 upgraded edition of the CAS Journal Ranking, International Journal of Pharmacy Practice is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of International Journal of Pharmacy Practice?
The journal's website gives an impact factor of 2.9 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 2.9, h-index 58.
How long does peer review take at International Journal of Pharmacy Practice?
Based on the dates recorded on 110 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 204 days (interquartile range 148–286 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of International Journal of Pharmacy Practice based?
Of the 22 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (7), Australia (6) and South Africa (3). Counted from the institutions listed on the board page; for reference only.
Which databases index International Journal of Pharmacy Practice?
According to LetPub and DOAJ records, International Journal of Pharmacy Practice is indexed in ESCI and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAB Abstracts and CINAHL; that list has not been checked against each database.
Is International Journal of Pharmacy Practice open access, and what is the APC?
International Journal of Pharmacy Practice is a hybrid journal. For open-access publication: APC about USD 3,070.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .